BridGene Biosciences
Operator of a biotechnology company intended to develop drugs for traditionally untreatable targets. The company combines technologies, including covalent chemistry, chemical proteomics, and quantitat...
Valuation
$0
Share Price
N/A
Total Raised
$78.5M
Last Round
N/A